Are We There Yet?
At AACR Meeting, Optimism That Progress Will Continue
By Anette Breindl
Wednesday, April 6, 2011
It might be called the cancer patient's theory of relativity: Even when drug development moves at record speed, that speed is still glacial from the perspective of the patient with cancer whose life expectancy may, in the worst cases, be measured in months.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.